GO
Loading...

Mixed Session For Generic Drugmakers

Monday, 25 Mar 2013 | 1:38 PM ET

CNBC's Seema Mody reports the latest from the Nasdaq: Drug makers Actavis and AstraZeneca reach an agreement to launch a Crestor generic in 2016.